Escherichia coli is the most preferred microorganism to express heterologous proteins for
therapeutic use, as around 30% of the approved therapeutic proteins are currently being …

The oxidoreductase horseradish peroxidase (HRP) is used in numerous industrial and
medical applications. In this review, we briefly describe this well-studied enzyme and focus …

Hepatitis C virus (HCV) infection represents a world health problem and no protective
vaccine or effective drug currently exists. For economic reasons, many patients use …

Abstract Background Hepatitis C virus (HCV) infection represents a worldwide health threat
that still needs efficient protective vaccine and/or effective drug. The traditional medicine …

Purpose To extend the study of the camel milk proteins which have antiviral activity against
HCV, camel naïve polyclonal IgGs, α-lactalbumin were purified from camel milk and their …

In 2007, the world solemnized the golden jubilee of the discovery of interferon (IFN).
Interferon is a small protein messenger called a pluripotent cytokine, produced by several …

Protein production can be improved if methods for soluble protein expression are
developed. Interferon consensus (IFN-con) is used to treat hepatitis C. IFN-con has superior …

Simple Summary As a result of increasing demand for the pleiotropic cytokine TNF-α,
recombinant human TNF-α protein with appropriate bioactivities was produced in several …

Recombinant consensus interferon (CIFN) is a therapeutic protein with molecular weight of
19.5 kDa having broad spectrum antiviral activity. Recombinant human CIFN (rhCIFN) has …

For the first time, we produced four lactoferricin (LFcin) peptides by a cell-free (in vitro)
method. These short antimicrobial peptides were expressed in an E. coli cell-free protein …